Tag: containment

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR

Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy

HONG KONG, Aug. 10, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its multicenter,...

ATN Reports Second Quarter 2025 Results; Reaffirms 2025 Outlook

Second Quarter 2025 vs. Second Quarter 2024 Financial Highlights

ePlus Reports First Quarter Fiscal Year 2026 Financial Results

~ Announces Initial Common Stock Quarterly Dividend of $0.25 Per Share and New Stock Repurchase Program ~ First Quarter Fiscal Year 2026 Consolidated net sales increased...

Inseego Reports Second Quarter 2025 Financial Results

Q2 2025 revenue of $40.2 million
Q2 2025 Adjusted EBITDA of $4.7 million and GAAP Net Income of $0.5 million
Paid off $14.9 million balance of 2025 Convertible Notes
Entered into a $15.0 million undrawn working capital facility for further operating flexibility and liquidity

ePlus Announces Initiation of Quarterly Cash Dividend

HERNDON, Va., Aug. 7, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ: PLUS), a leading provider of technology solutions, today announced that its Board of Directors...

Robust eDNA Monitoring Finds No Significant Impact on Natural Marine Microbial Communities in Gigablue’s Field Experiment

Comprehensive eDNA analysis of open ocean experiment demonstrates minimal environmental disruption from proprietary substrate deployment

Comprehensive eDNA analysis of open ocean experiment demonstrates minimal environmental disruption from proprietary substrate deployment

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

Sanofi completes the acquisition of Vigil Neuroscience, Inc.

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for...

Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader

Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs Respective Generics Businesses and Endo's Sterile Injectables Business to be Combined and Spun...

BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

LOUISVILLE, Ky., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2025, and increased Revenue and Adjusted EBITDA¹ guidance.

Pacific Health Care Organization, Inc. Reports its Second Quarter 2025 Financial Results

Irvine, July 31, 2025 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q announcing its financial results for the quarter ended June 30, 2025.

Iveco Group 2025 Second Quarter

The following is an extract from the “Iveco Group 2025 Second Quarter” press release. The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF:

Flow Sciences Announces New Office in North Carolina’s Research Triangle Park

LELAND, N.C., July 30, 2025 /PRNewswire/ -- Flow Sciences, a global leader in advanced containment solutions, today announced the opening of a new office...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsContainment

Global-e Announces Board Authorization of $500 Million Share Repurchase Program

Manual, Pre-programmed, and Physical AI Finishing Compared

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations